Biomarkers of drug response in colon cancer

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1048088

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Colorectal cancer is the third leading cause of cancer related death in Australia. While there are now a number of treatment options for patients with colon cancer, there is significant variability in response among patients to individual drugs. This NHMRC project grant will seek to identify genetic markers which predict the likelihood of a patient responding to a specific therapy. This will enable individual patients to be treated with the drug most likely to be of benefit to them.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2015

Funding Scheme: Project Grants

Funding Amount: $544,378.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

biomarkers | cancer chemotherapeutic agents | colon cancer | drug resistance | epigenetics

Related Links